Differentiating Alzheimer disease-associated aggregates with small molecules
- 31 December 2007
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 28 (3) , 251-260
- https://doi.org/10.1016/j.nbd.2007.07.018
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (AG14452, MH077621)
- National Human Genome Research Institute
- Alzheimer's Association
This publication has 49 references indexed in Scilit:
- High throughput screening for small molecule inhibitors of heparin-induced tau fibril formationPublished by Elsevier ,2007
- Characterisation of the binding of amyloid imaging tracers to rodent Aβ fibrils and rodent-human Aβ co-polymersBiochemical and Biophysical Research Communications, 2006
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006
- Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid FibrilsBiochemistry, 2005
- Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid FibrilsScience, 2005
- Lewy body-related ?-synucleinopathy in the aged human brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- Tau Conformational Changes Correspond to Impairments of Episodic Memory in Mild Cognitive Impairment and Alzheimer's DiseaseExperimental Neurology, 2002
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973